Roche Aktie
WKN: 891106 / ISIN: US7711951043
30.09.2025 18:54:43
|
Roche's Troponin T Test Offers New Level Of Accuracy Critical For Diagnosing Heart Attacks
(RTTNews) - Roche (RHHBY) Tuesday announced the primary results from the TSIX Study Program, which evaluated the performance of its new sixth-generation high-sensitivity Troponin T test for diagnosing heart attacks.
Presented at the European Society for Emergency Medicine (EUSEM) 20252 and the European Society of Cardiology (ESC) 20251, the study results showed that the Elecsys Troponin T hs Gen 6 test was able to identify acute myocardial infarction (AMI), or heart attack, and identify those not having an AMI, with a high level of precision.
This supports the efficient triage of patients arriving at the emergency department, ensuring healthcare resources can be focused where they are needed most. This data announcement follows the recent CE Mark approval for the test.
As one of the top three reasons for emergency care visits,4 chest pain creates significant anxiety and uncertainty for patients whilst putting pressure on healthcare services. Yet only one in every ten patients who presents with symptoms will actually be experiencing a heart attack.5 With 49% of emergency departments in Europe reporting overcrowding on a frequent basis,6 the ability to quickly and reliably identify those patients who are suffering from AMI, and to rule out those who are not, is crucial in ensuring the best possible outcomes for patients.
"Coronary artery disease continues to place an immense strain on global health systems, particularly in emergency care, where cases of chest pain are among the most challenging presentations to evaluate," said Matt Sause, CEO of Roche Diagnostics. "Our new test enables clinicians to detect even the smallest elevations in troponin levels - a critical biomarker for heart attack - with high confidence. This ensures that in a situation when every second counts, patients receive the life-saving care they need at the earliest opportunity, and emergency services can prioritise resources to deliver care effectively to those in urgent need."

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Roche Holding AG Sponsored American Deposit Receipt Repr 1/2 NVTGShmehr Nachrichten
01.09.25 |
Roche-Aktie schwächelt: Roche beginnt Phase-3-Test für Blutdruckmittel (Dow Jones) | |
21.07.25 |
Roche-Aktie im Minus: Roche meldet Rückschlag in COPD-Studie - Hauptziel verfehlt (Dow Jones) | |
23.06.25 |
Roche-Aktie gewinnt: Phase-III-Studienergebnisse zu Lunsumio fallen positiv aus (Dow Jones) | |
23.05.25 |
Roche-Aktie in Grün: Neue Hoffnung für Millionen - FDA gibt grünes Licht für Roches Susvimo (Dow Jones) | |
24.04.25 |
Roche-Aktie trotzdem in Rot: Roche überzeugt mit stabilem Wachstum und bestätigtem Ausblick (Dow Jones) | |
22.04.25 |
Roche-Aktie in Rot: Roche kündigt langfristige Milliardeninvestition in den USA an (Dow Jones) |